Global HIV Infection Drug Pipeline Analysis

News provided by

Dec 13, 2013, 10:30 ET

MUMBAI, December 13, 2013 /PRNewswire/ --

Bharat Book Bureau presents Global HIV Infection Drug Pipeline Analysis. This report provides the discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retroviral in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have been successful in improving the quality of life for HIV patients and prevented the virus from developing into AIDS. The rate of HIV infection and the number of deaths due to AIDS has been on a declining note at a positive rate across the globe. It has been estimated that the death rate reduced from 2.3 million in 2005 to 1.6 in 2012, with the rates for children being even much lower. A major cause for such drastic changes in the infection rates has been the improved access to antiretroviral drugs and therapy in recent years.

(Logo: http://photos.prnewswire.com/prnh/20130128/590935 )

Bharat Book Bureau presents the report entitled "Global HIV Infection Drug Pipeline Analysis" (http://www.bharatbook.com/healthcare-market-research-reports/global-hiv-infection-drug-pipeline-analysis.html ) It gives comprehensive insight on the various drugs being developed for the treatment of HIV Infection. Research report covers all the ongoing drugs being developed in various clinical development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the HIV Infection drug market based upon development process.

Following parameters for each drug profile in clinical development phase are covered in "Global HIV Infection Drug Pipeline Analysis" research report:

Drug Profile Overview
Alternate Names for Drug
Active Indication
Phase of Development
Mechanism of Action
Brand Name
Patent Information
Orphan Designation by Indication, Country & Organization
Country for Clinical Trial
Owner / Originator/ Licensee/Collaborator
Administrative Route
Drug Class
ATC Codes

HIV Infection Drug Development by Clinical Phase:

Research: 31
Preclinical: 140
Phase-I: 53
Phase-I/II: 18
Phase-II: 39
Phase-III: 7
Preregistration: 2
Registered: 2
Marketed: 34

Table of Contents

HIV Infection Drug Market Overview
HIV Infection Drug Clinical Development Phase: Research
Overview
HIV Infection Drug Profiles in Clinical Phases
HIV Infection Drug Clinical Development Phase: Preclinical
Overview
HIV Infection Drug Profiles in Clinical Phase
HIV Infection Drug Clinical Development Phase: Phase-I
Overview
HIV Infection Drug Profiles in Clinical Phase
HIV Infection Drug Clinical Development Phase: Phase-I/II
Overview
HIV Infection Drug Profiles in Clinical Phase
HIV Infection Drug Clinical Development Phase: Phase-II
Overview
HIV Infection Drug Profiles in Clinical Phase
HIV Infection Drug Clinical Development Phase: Phase-III
Overview
HIV Infection Drug Profiles in Clinical Phase
HIV Infection Drug Clinical Development Phase: Preregistration
Overview
HIV Infection Drug Profiles in Clinical Phase
HIV Infection Drug Clinical Development Phase: Registered
Overview
HIV Infection Drug Profiles in Clinical Phase
Marketed Drugs
Overview
Marketed Drug Profile

Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=430480

For more information on the report: http://www.bharatbook.com/healthcare-market-research-reports/global-hiv-infection-drug-pipeline-analysis.html

Related Reports:

Related Category:

About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us:

Poonam
Bharat Book Bureau
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
Blog: http://blog.bharatbook.com
E: [email protected]
W: http://www.bharatbook.com

SOURCE Bharat Book Bureau